827 related articles for article (PubMed ID: 9731744)
1. Modulation of insulin-like growth factor actions in L6A1 myoblasts by insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5: a dual role for IGFBP-5.
Ewton DZ; Coolican SA; Mohan S; Chernausek SD; Florini JR
J Cell Physiol; 1998 Oct; 177(1):47-57. PubMed ID: 9731744
[TBL] [Abstract][Full Text] [Related]
2. Raf-1 activation stimulates proliferation and inhibits IGF-stimulated differentiation in L6A1 myoblasts.
Samuel DS; Ewton DZ; Coolican SA; Petley TD; McWade FJ; Florini JR
Horm Metab Res; 1999; 31(2-3):55-64. PubMed ID: 10226782
[TBL] [Abstract][Full Text] [Related]
3. IGF-I increases IGFBP-5 and collagen alpha1(I) mRNAs by the MAPK pathway in rat intestinal smooth muscle cells.
Xin X; Hou YT; Li L; Schmiedlin-Ren P; Christman GM; Cheng HL; Bitar KN; Zimmermann EM
Am J Physiol Gastrointest Liver Physiol; 2004 May; 286(5):G777-83. PubMed ID: 15068962
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor-I-dependent signal transduction pathways leading to the induction of cell growth and differentiation of human neuroblastoma cell line SH-SY5Y: the roles of MAP kinase pathway and PI 3-kinase pathway.
Kurihara S; Hakuno F; Takahashi S
Endocr J; 2000 Dec; 47(6):739-51. PubMed ID: 11228049
[TBL] [Abstract][Full Text] [Related]
5. The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways.
Coolican SA; Samuel DS; Ewton DZ; McWade FJ; Florini JR
J Biol Chem; 1997 Mar; 272(10):6653-62. PubMed ID: 9045696
[TBL] [Abstract][Full Text] [Related]
6. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.
Guvakova MA; Surmacz E
Cancer Res; 1997 Jul; 57(13):2606-10. PubMed ID: 9205064
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone and the insulin-like growth factor system in myogenesis.
Florini JR; Ewton DZ; Coolican SA
Endocr Rev; 1996 Oct; 17(5):481-517. PubMed ID: 8897022
[TBL] [Abstract][Full Text] [Related]
8. Increased insulin sensitivity in IGF-I receptor--deficient brown adipocytes.
Mur C; Valverde AM; Kahn CR; Benito M
Diabetes; 2002 Mar; 51(3):743-54. PubMed ID: 11872675
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of insulin receptor substrate-2 and mitogen-activated protein kinase tyrosine phosphorylation by phosphatidylinositol 3-kinase inhibitors in SH-SY5Y human neuroblastoma cells.
Kim B; Leventhal PS; White MF; Feldman EL
Endocrinology; 1998 Dec; 139(12):4881-9. PubMed ID: 9832424
[TBL] [Abstract][Full Text] [Related]
10. Roles of insulin receptor substrate-1 and Shc on insulin-like growth factor I receptor signaling in early passages of cultured human fibroblasts.
Takahashi Y; Tobe K; Kadowaki H; Katsumata D; Fukushima Y; Yazaki Y; Akanuma Y; Kadowaki T
Endocrinology; 1997 Feb; 138(2):741-50. PubMed ID: 9003010
[TBL] [Abstract][Full Text] [Related]
11. The critical role of Shc in insulin-like growth factor-I-mediated mitogenesis and differentiation in 3T3-L1 preadipocytes.
Boney CM; Gruppuso PA; Faris RA; Frackelton AR
Mol Endocrinol; 2000 Jun; 14(6):805-13. PubMed ID: 10847583
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor binding protein-5 modulates muscle differentiation through an insulin-like growth factor-dependent mechanism.
James PL; Stewart CE; Rotwein P
J Cell Biol; 1996 May; 133(3):683-93. PubMed ID: 8636241
[TBL] [Abstract][Full Text] [Related]
13. Insulin receptor substrate 2 and Shc play different roles in insulin-like growth factor I signaling.
Kim B; Cheng HL; Margolis B; Feldman EL
J Biol Chem; 1998 Dec; 273(51):34543-50. PubMed ID: 9852124
[TBL] [Abstract][Full Text] [Related]
14. Roles of insulin-like growth factor (IGF) receptors and IGF-binding proteins in IGF-II-induced proliferation and differentiation of L6A1 rat myoblasts.
Bach LA; Salemi R; Leeding KS
Endocrinology; 1995 Nov; 136(11):5061-9. PubMed ID: 7588242
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor (IGF)-binding protein-related protein-1: an autocrine/paracrine factor that inhibits skeletal myoblast differentiation but permits proliferation in response to IGF.
Haugk KL; Wilson HM; Swisshelm K; Quinn LS
Endocrinology; 2000 Jan; 141(1):100-10. PubMed ID: 10614628
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine phosphorylation-dependent and -independent role of Shc in the regulation of IGF-1-induced mitogenesis and glycogen synthesis.
Sasaoka T; Ishiki M; Wada T; Hori H; Hirai H; Haruta T; Ishihara H; Kobayashi M
Endocrinology; 2001 Dec; 142(12):5226-35. PubMed ID: 11713219
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor (IGF) binding protein-5 blocks skeletal muscle differentiation by inhibiting IGF actions.
Mukherjee A; Wilson EM; Rotwein P
Mol Endocrinol; 2008 Jan; 22(1):206-15. PubMed ID: 17885206
[TBL] [Abstract][Full Text] [Related]
18. Insulin signaling leading to proliferation, survival, and membrane ruffling in C2C12 myoblasts.
Conejo R; Lorenzo M
J Cell Physiol; 2001 Apr; 187(1):96-108. PubMed ID: 11241354
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling.
Cousin SP; Hügl SR; Myers MG; White MF; Reifel-Miller A; Rhodes CJ
Biochem J; 1999 Dec; 344 Pt 3(Pt 3):649-58. PubMed ID: 10585851
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of insulin-like growth factor (IGF) binding protein-3 synthesis by IGF-I and transforming growth factor-alpha is mediated by both phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways in mammary epithelial cells.
Sivaprasad U; Fleming J; Verma PS; Hogan KA; Desury G; Cohick WS
Endocrinology; 2004 Sep; 145(9):4213-21. PubMed ID: 15192040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]